L-Carnitine
Amino-acid derivative
A quaternary ammonium compound referenced as a metabolic adjunct in fatty-acid transport research.
Also referenced as: Levocarnitine
Overview
L-carnitine is a naturally occurring quaternary amine derived from the amino acids lysine and methionine. The body synthesizes it (mainly in liver and kidney) and it is also obtained from the diet, particularly red meat. It is not a peptide.
At a glance
What L-Carnitine does
L-carnitine is a small quaternary-ammonium compound whose central job is to shuttle long-chain fatty acids into the mitochondria so they can be burned for energy. Long-chain fatty acyl groups cannot cross the inner mitochondrial membrane on their own; the carnitine shuttle solves this. Carnitine palmitoyltransferase I (CPT1) on the outer membrane transfers the fatty acyl group onto carnitine, the carnitine-acylcarnitine translocase moves it across the inner membrane, and CPT2 hands it back to coenzyme A inside the matrix, where beta-oxidation proceeds. Without adequate carnitine, long-chain fat oxidation stalls - which is why carnitine is described as a fat-metabolism cofactor rather than a fat-burning drug in its own right.
Beyond transport, L-carnitine buffers the mitochondrial acyl-CoA/free-CoA ratio, mopping up excess acyl groups (as acylcarnitines) and keeping free coenzyme A available for other reactions, and it helps clear potentially toxic acyl intermediates. These housekeeping roles matter in tissues with high fat-oxidation demand such as skeletal and cardiac muscle.
The strongest human evidence is in genuine carnitine deficiency - primary carnitine transporter defects or secondary deficiency (dialysis, certain drugs, some metabolic disorders) - where supplementation clearly restores fat oxidation and corrects symptoms. In carnitine-replete healthy people the case for boosting fat loss or endurance performance is much weaker and inconsistent, partly because oral absorption is limited and muscle carnitine content is tightly regulated. So its actions are well defined biochemically, with proven benefit narrowly in deficiency and mixed results as a performance or weight adjunct.
Effects reported in research
- Enables mitochondrial import of long-chain fatty acids via the CPT1 / carnitine-acylcarnitine translocase / CPT2 shuttle, the rate-controlling step of long-chain fat oxidation (established biochemistry).
- Buffers the mitochondrial acyl-CoA/free-CoA ratio, keeping free coenzyme A available for other metabolic reactions (established biochemistry).
- Sequesters and helps clear excess or potentially toxic acyl intermediates as acylcarnitines (established biochemistry).
- Restores fat oxidation and corrects symptoms in primary carnitine deficiency (transporter defect) - the clearest human clinical benefit (human clinical).
- Corrects secondary carnitine deficiency states such as in dialysis patients and certain drug-induced or metabolic-disorder cases (human clinical).
- Supports energy metabolism in high-fat-oxidation tissues like cardiac and skeletal muscle (established physiology).
- Shows inconsistent, generally modest effects on fat loss or endurance performance in carnitine-replete healthy people, limited by tight regulation of muscle carnitine and poor oral bioavailability (mixed human evidence).
Effects listed reflect findings reported in the research literature — many in animal or in-vitro models. Listing an effect is not a claim of efficacy or a therapeutic indication in humans.
Mechanism of action
L-carnitine is essential for transporting long-chain fatty acids across the inner mitochondrial membrane (via the carnitine shuttle, involving carnitine palmitoyltransferase enzymes) so they can undergo beta-oxidation for energy production. It also helps buffer the mitochondrial acyl-CoA/CoA ratio.
Mechanistic description reflects published research-literature understanding. Much peptide research is preclinical (in-vitro or animal-model); mechanism in humans may differ and is not established for many compounds.
What it's studied for
Research contexts in which L-Carnitine appears in the literature. Listing a research area is not a claim of efficacy or a therapeutic indication.
Key characteristics
- An amino-acid-derived compound, NOT a peptide
- Central to the mitochondrial carnitine shuttle for fatty-acid transport
- Endogenously synthesized and also obtained from diet
- Levocarnitine is an approved treatment for carnitine deficiency
- Sold broadly as a dietary supplement; performance/weight claims have mixed evidence
Reported research dosing reference only
Educational reference, not dosing guidance. The figures below summarize amounts reported in published research and research-community protocols, provided for educational and research context only. They are not medical advice, not a recommendation, and not instructions for human use. L-Carnitine is a research compound.
L-carnitine is used in metabolic research and in compounded lipotropic solutions, where amounts are formulation-specific. Any figures are reference values from research/compounding contexts, not human dosing guidance.
- Injectable research/compounding solutions: commonly formulated in the low-hundreds-of-mg range per dose, formulation-dependent
- As a component of lipotropic (Lipo-C) blends: often around 15 mg/mL alongside MIC components
These are reference figures for research context only, not dosing guidance for humans. L-carnitine is a small-molecule nutrient, not a peptide.
How it compares
Unlike the research peptides here, L-carnitine is an endogenous metabolite with a defined role in mitochondrial fatty-acid transport and an approved deficiency indication.
Commonly studied alongside
Compounds frequently researched together with L-Carnitine in the literature. Cross-referenced for research context — not a usage or combination recommendation.
Handling & Stability
Liquid research solutions are typically stored cold and used within supplier-stated shelf life.
- Avoid repeated freeze-thaw cycles
- Verify supplier lot and Certificate of Analysis
- Follow institutional lab-safety protocols
Analytical & COA Concepts
Reputable research suppliers publish a third-party Certificate of Analysis per batch. Key analytical concepts referenced in COAs include:
Category Context
L-Carnitine sits in the Research Solutions & Adjuncts area of the PeptiDex library.
- Entry type: Research solution / adjunct
- Browse the full library →
- Glossary of terms →
Where researchers source L-Carnitine
For researchers studying L-Carnitine, third-party suppliers such as Practically Natty Peptides offer research-grade material with third-party Certificates of Analysis and US-based shipping.
PeptiDex does not maintain a direct supplier listing for this compound. The link above goes to a third-party research-supplier directory.
Frequently asked questions
What is L-carnitine as a research solution?
L-carnitine is a naturally occurring amino-acid-derived compound (not a peptide) that plays a role in shuttling long-chain fatty acids into mitochondria for beta-oxidation. In the research-solutions context it is supplied as an injectable/metabolic research solution and is often included in lipotropic blends. It is studied for its role in fatty-acid transport and energy metabolism.
How does L-carnitine differ from a peptide compound?
L-carnitine is a small quaternary-ammonium metabolite (a derivative of the amino acids lysine and methionine), not a chain of amino acids linked by peptide bonds. It therefore has no sequence, no lyophilization/reconstitution workflow like a peptide, and behaves as a small-molecule nutrient in solution rather than a research peptide.
Why is L-carnitine grouped with lipotropic research solutions?
Because of its role in fatty-acid transport for energy production, L-carnitine is commonly formulated alongside lipotropic agents such as MIC (methionine/inositol/choline) blends. In these research solutions it is included for its metabolic transport function rather than as a standalone weight-loss agent, and controlled human efficacy evidence for that purpose remains limited.
How is L-carnitine supplied and stored?
As a water-soluble small molecule it is typically supplied as a ready-made sterile solution rather than a lyophilized powder, stored per the compounding source's directions. Unlike peptides it does not require reconstitution from a lyophilized cake. A COA documenting concentration and purity is reasonable to expect from a research supplier.
Answers are educational summaries of research-literature context and do not constitute medical advice. See the Research Library, COA guide, and Storage & Handling guide for more.